A state-of-the-art review highlights the use of multimodal imaging and AI to improve diagnosis and management of radiation-induced brain injury (RIBI).
Key Details
- 1Radiation-induced brain injury (RIBI) is a complex complication following cranial radiotherapy, impacting neurological function and quality of life.
- 2Multimodal imaging methods—including structural/functional MRI, diffusion and perfusion imaging, PET/CT, and radiomics—enhance early detection and differential diagnosis of RIBI versus tumor recurrence.
- 3AI techniques and machine learning models enable extraction of quantitative features, promising improved non-invasive diagnosis accuracy.
- 4Current interventions are shifting towards targeted, mechanism-driven therapies; Bevacizumab remains the only validated drug for radiation necrosis, while experimental approaches like stem cell therapy and neuromodulation are under study.
- 5Major challenges include lack of unified diagnostic criteria, early biomarkers, and seamless clinical integration of multimodal imaging and AI.
- 6The article calls for standardized protocols, expanded research, and multidisciplinary collaboration to achieve precision management.
Why It Matters
RIBI is an increasingly recognized complication given longer brain tumor survival, yet its diagnosis remains difficult using conventional imaging. Integrating advanced multimodal techniques and AI-driven analysis could transform early detection and precision treatment, representing a critical area for radiology and imaging AI innovation.
Source
EurekAlert
Related News
•EurekAlert
AI Model Improves Differentiation of Brain Tumor Progression from Radiation Necrosis on MRI
A York University-led study shows a novel AI using advanced MRI can distinguish between progressive brain tumors and radiation necrosis more accurately than human assessment.
•EurekAlert
AutoML Model Accurately Differentiates Brain Tumors on MRI
Thomas Jefferson University researchers developed an AutoML model that distinguishes pituitary macroadenomas from parasellar meningiomas on MRI with over 97% accuracy.
•EurekAlert
Survey: Public Trusts Doctors Over AI, But Embraces AI For Cancer Diagnosis
Most people trust doctors more than AI for health diagnoses, but see significant potential for AI tools in cancer detection.